Synergistic Cancer Treatment Systems

The present invention relates to novel systems for treating cancer by combining pharmaceutical compositions containing tucaresol or its analogs with distinct technologies, such as AI, IoT, blockchain, and new materials, to create a more powerful and effective treatment approach.

The original patent disclosed pharmaceutical compositions containing tucaresol or its analogs for treating cancer. However, the patent did not provide a comprehensive solution for tracking patient responses, analyzing genomic data, or optimizing treatment regimens. The present invention addresses these limitations by integrating the patented compositions with other distinct technologies to create a more holistic treatment approach.

The new inventive concept comprises systems and methods for treating cancer that integrate pharmaceutical compositions containing tucaresol or its analogs with AI, IoT, blockchain, and new materials. For example, a system may include a blockchain-based data management platform for tracking patient responses to the composition, an AI-powered analysis of a patient's genomic data to personalize treatment, or an IoT device for monitoring patient vital signs. The inventive concept enables a more targeted, efficient, and effective treatment approach by leveraging the strengths of each technology.

The new claims introduce a novel combination of the patented pharmaceutical compositions with distinct technologies, such as AI, IoT, blockchain, and new materials. This integration provides a non-obvious solution to the limitations of the original patent, as it enables a more comprehensive and effective treatment approach.

Alternative embodiments of the inventive concept may include integrating the pharmaceutical compositions with other technologies, such as robotics, nanotechnology, or 3D printing. Variations of the inventive concept may also include using different types of cancer or different patient populations.

The inventive concept has significant commercial potential in the cancer treatment market, particularly in the areas of personalized medicine, precision oncology, and digital health. The target industries include pharmaceutical companies, healthcare providers, and medical technology companies.